News related to
prove no

Anthropic’s updated stock market filing has sharpened attention on cryptocurrency derivatives linked to the Claude developer, with traders betting on its valuation before shares begin trading on Nasdaq. The company submitted another amendment to its registration statement to the US Securities and Exchange Commission on 17 November, setting out an indicative price range of $70 to $78 a share for an offering of 825 million shares. The […]

President Prabowo Subianto witnesses memoranda on smart cities, appliance manufacturing and coal-to-ethanol; three Chinese financial institutions propose a renminbi financing framework of up to USD 10 billion with Danantara

SHENZHEN, CHINA – Media OutReach Newswire – 18 November 2026 – Indonesian and Chinese companies and institutions today set out four areas of cooperation with a combined indicative value of USD 63 billion, during APEC Economic Leaders’ Week in Shenzhen. President Prabowo Subianto of the Republic of Indonesia witnessed the signing of memoranda of understanding on smart cities, home-appliance manufacturing and technology, and coal-to-ethanol fuel production.

President Prabowo Subianto meets the Chinese consortium delegation ahead of the APEC 2026 MoU Ceremony.
President Prabowo Subianto meets the Chinese consortium delegation ahead of the APEC 2026 MoU Ceremony.

On 17 November, three Chinese financial institutions held discussions with PT Danantara Asset Management on a proposed renminbi financing framework of up to USD 10 billion equivalent for Indonesian infrastructure.

The four initiatives bring Chinese capital, engineering and process technology to priorities the Government of Indonesia has set for this decade: housing, industrial capacity, energy independence and the infrastructure that supports them. The Chinese parties described their participation as an expression of confidence in Indonesia’s economy and in the direction of its government.

The four initiatives

Initiative Indonesian party Chinese parties Indicative value
Smart cities PT Kota Masa Depan Indonesia (KMDI) Consortium led by Shaanxi Construction Engineering Group, with Hisense and other Chinese companies USD 50 billion (10 cities at USD 5 billion each)
Infrastructure financing PT Danantara Asset Management Changjiang Securities International, Shanghai Pudong Development Bank Hong Kong Branch, SDIC Securities (Hong Kong) Up to USD 10 billion equivalent (USD 5 billion panda bonds, USD 5 billion dim sum bonds)
Coal-to-ethanol Badan Industri Mineral (BIM) Beijing Petrochemical Engineering (BPE) USD 2 billion
Appliance manufacturing and technology Government of Indonesia; Institut Teknologi Bandung Hisense USD 1 billion
Total USD 63 billion

Funds raised under the financing framework can also be used for the smart-city programme, so up to USD 10 billion of the total may overlap.

Infrastructure financing: up to USD 10 billion in renminbi

Changjiang Securities International Financial Group Limited, Shanghai Pudong Development Bank Co., Ltd. Hong Kong Branch and SDIC Securities (Hong Kong) Limited held a constructive exchange of views with PT Danantara Asset Management on an infrastructure financing partnership on 17 November 2026.

The discussions centre on a proposed programme of long-term financing of up to USD 10 billion equivalent for projects undertaken by Danantara Asset Management on behalf of the Government of the Republic of Indonesia. The renminbi-based framework would be assembled in two parts: USD 5 billion equivalent through panda bonds in mainland China’s interbank market and USD 5 billion equivalent through dim sum bonds in Hong Kong. Funds would be deployed in stages that follow each project’s construction and drawdown profile, at a pace set by a joint project pipeline.

The proposed financing targets power generation and grid modernisation; renewable energy, storage and transmission; downstream mineral processing and industrial estates; advanced manufacturing; digital infrastructure and data centres; transport and logistics; and healthcare. It can also be applied to the smart-city programme.

The participation of the three institutions, coordinated with PT Danantara Asset Management, reflects the breadth of institutional interest in Indonesia’s development agenda. It does not indicate that any institution has irrevocably committed funds.

“Three of China’s established financial institutions have come together to build a long-term renminbi financing framework with Indonesia. That reflects our confidence in where the Indonesian economy is heading. The funds are intended for modern power grids, data centres and advanced manufacturing, the technology base that the next generation of investors will look for when they come to Indonesia.”

Han Changrun (Bill), Head of Debt Capital Markets, SDIC Securities (Hong Kong) Limited

Smart cities: homes for about 3 million people

PT Kota Masa Depan Indonesia (KMDI), the project entity 99% owned by PT Danantara Asset Management, signed a non-binding memorandum of understanding with a consortium led by Shaanxi Construction Engineering Group Corporation Limited. Hisense and other Chinese companies are members of the consortium.

The programme serves the Government of Indonesia’s national smart city plan. It envisages 10 cities at an indicative USD 5 billion each, with approximately 1.5 million housing units and supporting infrastructure for about 3 million residents. The consortium expects to deliver public amenities, municipal works, utilities and digital infrastructure over the next three to five years, subject to the required procurement process.

Each city is planned as a set of complete neighbourhoods. The housing mix covers affordable and family homes, rental and worker housing, resettlement housing and senior-friendly residences. Around them the plan places schools from kindergarten to university level, hospitals and community health centres, mosques and other places of worship, markets, parks and municipal service centres.

Utilities and digital systems are designed in from the start: water treatment and supply, wastewater networks, flood protection, waste recycling, power distribution with solar generation, fibre networks, and command centres that monitor traffic and utilities.

“A city planned from the start with digital services, clean water and efficient energy gives Indonesian families a better place to live and gives investors a clear picture of how Indonesia intends to build. We bring engineering and smart-city experience that we want to apply here, and we see Indonesia as a market worth committing to for the long term.”

Yang Haisheng, President, Shaanxi Construction Engineering Group Co., Ltd. (SCEGC)

Hisense: manufacturing, a joint laboratory and rural supply

Hisense signed a memorandum of understanding advancing its investment programme in Indonesia, with Chairman Jia Shaoqian taking part. The appliance factory and the programme’s other investments carry an indicative value of USD 1 billion. The signing follows the memorandum of strategic cooperation Hisense concluded with BPI Danantara in May 2026.

Manufacturing. Hisense plans to establish in Indonesia its largest home-appliance manufacturing facility outside China, serving the domestic market and exports. Scale, site and timeline will be defined in due course. Hisense will increase its manufacturing investment in step with demand from Indonesia’s Koperasi Merah Putih programme, under which the government plans around 80,000 village and urban cooperatives to shorten distribution chains for essential goods.

Joint laboratory. Hisense and Institut Teknologi Bandung (ITB) are establishing a laboratory, funded by Hisense, in support of Indonesia’s household transition from gas to electricity. The two sides will develop energy-efficient appliances suited to Indonesian homes and run joint professional training. The laboratory builds on Hisense’s research memorandum of 13 August 2026 with the Ministry of Higher Education, Science, and Technology.

Education and skills. In 2025 Hisense supplied interactive teaching displays to nearly 300,000 classrooms across more than 6,000 islands under Indonesia’s national education programme. It is continuing to invest in digital education and has proposed sponsoring Indonesian children for skills training, subject to an agreed programme with the relevant partners.

Smart cities and public projects. Hisense is a member of the smart-city consortium and intends to express interest in national tenders in displays, smart home technology and digital infrastructure.

“We plan to put our largest appliance factory outside China in Indonesia and to fund a laboratory with ITB alongside it. That means technology will be developed here as well as assembled here. When a global manufacturer makes that choice, other companies weighing Indonesia take notice.”

Jia Shaoqian, Chairman, Hisense Group Co., Ltd.

Coal-to-ethanol: domestic fuel from low-grade coal

Beijing Petrochemical Engineering Co., Ltd. (BPE) signed a memorandum of understanding with Badan Industri Mineral (BIM), the Agency for Mineral Industry of the Republic of Indonesia, on coal-to-ethanol cooperation with an indicative value of USD 2 billion. The chairman of each party attended.

The memorandum sets out cooperation to convert Indonesia’s low-grade coal into ethanol for transport fuel, with production and refining based in Indonesia for the Indonesian market. Producing ethanol at home would reduce dependence on imported fuel, add value to a resource Indonesia holds in abundance, create skilled industrial jobs and keep more of the nation’s energy spending inside its own economy.

BPE holds multiple patents across process technologies and specialised equipment, including coal-based ethanol technology. Its coal-to-ethanol process package was developed jointly with the Dalian Institute of Chemical Physics, Chinese Academy of Sciences. BIM, established under Presidential Regulation No. 76 of 2025, supports the domestic processing and use of Indonesia’s resources for maximum added value.

“Indonesia has large reserves of low-grade coal and a growing need for fuel produced at home. This cooperation brings proven process technology to connect the two. It also shows that Indonesia is open to partners who bring new technology and are prepared to process its resources in the country.”

Jiantao Xu, Chairman & Secretary of the Party Committee, Beijing Petrochemical Engineering Co., Ltd. (BPE)

APEC Shenzhen

China is hosting the 33rd APEC Economic Leaders’ Meeting in Shenzhen on 18 and 19 November 2026 under the theme “Building an Asia-Pacific Community to Prosper Together”. President Prabowo is attending the leaders’ meeting and the APEC CEO Summit. Indonesia’s priorities at the summit are regional resilience, food and energy security, and trade that benefits small businesses and households.

APEC’s digital and artificial intelligence ministers have agreed to promote AI-enabled urban governance, better digital infrastructure and digital inclusion across urban and rural areas. The smart-city memorandum is aligned with that direction.

About the parties

  • PT Danantara Asset Management undertakes projects on behalf of the Government of the Republic of Indonesia. It is part of Danantara Indonesia, launched by President Prabowo in February 2025.
  • PT Kota Masa Depan Indonesia (KMDI) is the smart-city project entity, 99% owned by PT Danantara Asset Management.
  • Badan Industri Mineral (BIM) is Indonesia’s Agency for Mineral Industry, established under Presidential Regulation No. 76 of 2025.
  • Shaanxi Construction Engineering Group Co., Ltd. (SCEGC) leads the smart-city consortium.
  • Hisense Group Co., Ltd. is a home-appliance and consumer-electronics manufacturer headquartered in Qingdao.
  • Beijing Petrochemical Engineering Co., Ltd. (BPE) is an engineering company with patented coal-based ethanol technology.
  • Changjiang Securities International, Shanghai Pudong Development Bank Hong Kong Branch and SDIC Securities (Hong Kong) are the three financial institutions in the proposed financing framework.

The issuer is solely responsible for the content of this announcement.

Arabian Post Staff -Dubai Flydubai has completed a solar power installation at its Dubai campus that is expected to prevent 1,169 tonnes of carbon dioxide emissions annually, as the airline seeks to reduce electricity consumption from conventional sources. The 1,113-kilowatt-peak project combines rooftop panels with solar car park structures and will produce more than 1.7 gigawatt-hours of electricity a year, the carrier announced on Tuesday. Positive Zero, […]

The Czech National Bank has completed its first issuance of tokenised bonds, testing near-instant settlement and securities transactions on distributed-ledger infrastructure as it evaluates new tools for monetary operations and reserve management. The pilot, disclosed on 10 November, involved koruna-denominated central bank debt issued through the Central Securities Depository in Prague. Tests conducted during October and November covered transfers, purchases and sales against payment, interest payments and […]

The United Democratic Front government has proposed stopping new bar licences for three-star hotels while allowing establishments already operating to retain their licences, under a draft liquor policy awaiting political and Cabinet approval. The proposal, emerging on Wednesday, is intended to restrict the expansion o…
Chief Minister V D Satheesan acknowledged heated exchanges at Wednesday’s cabinet meeting but rejected suggestions that the disagreements exposed divisions within his six-month-old United Democratic Front government. Speaking to journalists in New Delhi, Satheesan said ministers had argued over policy questions during…

By K Raveendran The extraordinary scenes unfolding within and outside the Supreme Court of India are disturbing manifestations of a deeper malaise afflicting the country’s democratic institutions. The spectacle of a lawyer being escorted out of a courtroom after making offensive remarks against Chief Justice of India Surya Kant represents more than an isolated breach […]

The article Erosion Of Institutional Authority Threatens Foundations Of Indian Democracy appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

Advertisements

Iron ore may need to fall to about $80 a tonne before costly mines curb production enough to stabilise prices, according to assessments by two Chinese research groups. Mysteel and the research arm of state-owned buyer China Mineral Resources Group identified the threshold at an industry conference in Xiamen last week, challenging expectations that production costs would protect the market closer to $90 a tonne. Their estimates […]

Phai-A1 supports million-token context and local deployment; Phai-M1 improves the quality of generated live-action-style video.

BEIJING, CHINA/HONG KONG SAR – Media OutReach Newswire – 18 November 2026 – Phancy Group Co., Ltd. (“Phancy” or “the Group”, stock code: 6682.HK), a leading full-stack enterprise-AI cloud services platform, announced the launch of two models developed in-house as part of its Phai series. Phai-A1 is a general-purpose language model optimized for efficient inference and long-context processing in applications such as software development and AI assistants. It supports a native one-million-token context window and can be deployed locally on a personal computer. Phai-M1 is a video generation model designed to improve how people appear and move in live-action-style footage, enhance visual detail and synchronize visuals with audio.

Dr. Dai Wenyuan, Founder and Chief Executive Officer of Phancy, said, “The AI industry is moving from competition over model capabilities to a phase in which computing infrastructure, models and applications are developed together. The Phai series is an important step in strengthening our full-stack AI capabilities. By optimizing our in-house models and computing platforms together, we can connect the underlying infrastructure with business applications and make our models better suited to practical business needs. Feedback from real-world use will help us refine the models, strengthen our technology and make our products more competitive.”

Phai–A1 Supports Efficient Inference and Local Deployment

Phai-A1 supports code generation, bug fixing, tool use and multistep tasks. In tests conducted under equivalent single-GPU conditions and using identical coding-agent tasks, Phai-A1 responded approximately 8 to 10 times as fast as Qwen 27B. For workloads that involve frequent model calls and require low latency, enterprises can run a lightweight model on demand to shorten response times and manage inference costs.

Phai-A1 performed well on software engineering benchmarks including SWE-bench Verified, SWE-bench Pro and SWE-bench Multilingual. On some evaluations, its results were comparable to those of models with more parameters. Phai-A1 natively supports a context window on the scale of one million tokens. Its post-training data covered very long texts. The model can process entire code repositories, long documents and large volumes of material, and support extended multi-turn conversations and complex tasks.

Developers and enterprises can also run Phai-A1 locally on a personal computer, depending on available hardware and data compliance requirements. This gives them more flexibility in how they deploy the model, manage data and control costs.

Phai–M1 Generates Synchronized Video and Audio for Live-Action Content

Phancy trained Phai-M1 with a focus on live-action film and television scenes. The model is designed to render facial expressions and body movements more naturally, improve visual detail and reduce common distortions in AI-generated video. It supports productions such as live-action series and AI-generated short-form dramas.

Phai-M1 generates visuals and synchronized audio in a single workflow. In testing, it generated a 15-second video at 720p resolution in about three minutes. For production teams and content studios that need a steady supply of footage, generation time is a factor in planning schedules and costs.

Computing Platform Optimization and Product Integration

With support from the ModelHub XC community, the Phai series completed a dedicated, end-to-end post-training optimization process tailored to the operating characteristics of Huawei’s Ascend computing platform. The Phai series is integrated with Phancy’s ModelHub XC, HAMi and ModelSphere products and with applications including PhanthyCode and PhanthyMovie. These integrations connect model development, computing infrastructure and AI applications.

Planned Release of Model Weights

Phancy plans to make the weights for Phai-A1 and Phai-M1 available to developers worldwide in the near future. The Group will continue to refine the models, work with technology partners and use developer feedback to guide updates. It will also expand use of the Phai series in software development, AI-assisted office work and video creation, and support private deployment in enterprise environments.

Users can try the Phai models at https://phai.phanthy.com.

Hashtag: #Phancy #PhaiA1 #PhaiM1

The issuer is solely responsible for the content of this announcement.

About Phancy Group

Phancy Group (6682.HK) is a leading full-stack AI cloud services platform, providing comprehensive solutions for the AI 2.0 era. Our offerings include SageAIOS, HAMi vGPU and ModelHub XC, delivering efficient and scalable AI infrastructure with end-to-end capabilities. We provide a complete solution from heterogeneous compute resource management and optimization to the deployment of intelligent agent models. These solutions empower digital transformation across a wide range of industries, supporting our vision of building a large-scale and efficient “Token Factory.”

Guided by the mission of “Everyone for AI,” Phancy Group is committed to bringing together more technologies, enterprises and developers to advance AI together.

Singapore has outlined three national artificial intelligence initiatives to combat financial scams, improve business lending and enable automated financial transactions, Deputy Prime Minister Gan Kim Yong said on Wednesday.

The programmes will bring banks, technology companies, researchers and public agencies together to develop shared AI capabilities and test them before wider deployment, Gan told the Singapore FinTech Festival. He also chairs the Monetary Authority of Singapore (MAS), which will oversee critical elements of the work.

The first initiative targets financial crime by improving the detection of suspicious transfers across banks. Gan said scam proceeds can move through several institutions within minutes, making it difficult for any single lender to recognise the full sequence of transactions and intervene before funds disappear. The effort is designed to link insights across the banking system without depending solely on alerts generated within individual institutions.

Five banks are already participating in a trial that securely combines transaction data to train and assess AI models. The exercise is intended to identify patterns that individual institutions might miss, while informing plans for a broader system to detect scams throughout Singapore’s banking network.

MAS will begin a design study in early 2027 for an industry-wide Scam Detection Utility, examining its technical blueprint, governance arrangements and operating model. Its initial focus will be domestic accounts and information, although officials see potential for cross-border cooperation later.

The second initiative seeks to improve access to credit for small and medium-sized enterprises and start-ups that lack extensive financial histories or assets to pledge as collateral. Traditional assessments can depend heavily on past repayments, guarantees and security, potentially overlooking businesses with viable prospects but limited records.

Gan said information relevant to credit decisions is often dispersed among bank accounts, invoices, payment records, business profiles and government databases. AI could help lenders assess a wider set of indicators, speed up decisions and potentially lower borrowing costs, provided the data can be used appropriately.

Technology companies will be invited to develop and test lending tools using realistic synthetic data rather than relying initially on actual customer records. Banks and public agencies will contribute expertise and information, while participating businesses will be consulted on whether the proposed tools address their financing difficulties. The proposed assessments would supplement rather than automatically replace existing credit decisions.

The government also wants to explore whether AI could help lenders identify businesses approaching a financing need and offer suitable options proactively. Such applications remain proposals for testing rather than established lending services, and their usefulness will depend on the performance of the systems being developed.

The third initiative examines transactions conducted by AI agents acting for individuals and companies. Trials will assess whether software can execute purchases or release contractual payments automatically once predefined conditions have been fulfilled and verified, without requiring separate manual instructions for every step.

Gan stressed that greater autonomy would not remove responsibility from the organisations authorising those agents. Systems must operate within defined permissions and limits, with safeguards covering identity verification, authorisation, accountability and compatibility across different financial platforms.

One area of testing involves purpose-bound money, under which the conditions governing a payment are specified in advance. Officials want to establish how AI agents could use such arrangements without exceeding their authority or compromising confidence in financial transactions.

The Future of Finance Institute, which began operations this month, will coordinate work involving financial institutions, technology developers and researchers. Its remit includes developing common standards, resources for managing AI risks and practical approaches that can be adopted beyond individual pilot projects.

The initiatives form part of Singapore’s wider national AI programme announced in its 2026 Budget. Gan said authorities would assess promising applications against international practices before considering broader deployment as the work moves into trials, rather than assuming that successful demonstrations would automatically translate into reliable commercial systems.

Separately, he announced the release of a second-phase report on the next generation of PayNow, Singapore’s instant payment service. The proposals include an SGQR+ switching arrangement intended to let residents and visitors make QR-code payments through their preferred compatible applications.

The announcements come as Singapore faces uncertainty over access to advanced computing equipment following new United States export controls. Gan said the government was engaging American officials and affected companies on the implications, while reiterating that businesses operating through Singapore must comply with applicable laws.

Mukesh Ambani’s Reliance is exploring manufacturing partnerships for a proposed constellation of 1,600 broadband satellites, seeking to develop domestic production capacity for a network designed to compete with Elon Musk’s Starlink.

The group is holding discussions with satellite manufacturers, technology start-ups and industrial companies, with potential arrangements including funding for production infrastructure. The negotiations remain preliminary, and no manufacturing agreements or firm procurement commitments have been publicly confirmed.

The project would create a low Earth orbit communications network primarily serving India, with completion now envisaged by 2035. It is intended to expand the satellite broadband capabilities of Jio Platforms, the listed digital services business controlled by Reliance Industries.

Reliance is considering a combination of locally produced spacecraft and imported satellites. Its plans under discussion include purchasing at least 400 satellites from the United States, while two American suppliers and potential European manufacturers are being evaluated. Those procurement discussions have not been announced as completed contracts.

A test mission is targeted for September 2027, followed by wider deployment from early 2028. The proposed completion date has moved from an earlier 2030 ambition because of constraints on manufacturing and rocket launches. These milestones remain targets rather than confirmed launch schedules.

The scale presents a significant industrial challenge. People familiar with the planning estimate that domestic satellite production currently amounts to fewer than 15 spacecraft annually, compared with output of approximately 200 a year that Reliance’s programme could require. That comparison underlines the need for new assembly facilities, specialist suppliers and testing capacity. Satellite components would also have to meet demanding standards for reliability, communications performance and sustained operation in orbit.

Rocket availability may prove equally important. Placing hundreds of satellites into low Earth orbit requires launches at a frequency and payload scale that India’s existing providers would need to expand substantially. Reliance has separately explored launch arrangements involving the Indian Space Research Organisation, Skyroot Aerospace and other providers, while assessing international options.

Amal Chandran, chief executive of satellite manufacturer HEX20, said manufacturing expansion was feasible but securing enough launches would be the principal obstacle if the constellation relied on domestic rockets. The availability of launch vehicles capable of carrying multiple spacecraft would influence deployment speed and costs.

Reliance has not disclosed a definitive investment budget, satellite manufacturing contract or binding launch programme for the constellation. Nor has it publicly identified the companies that would build the proposed spacecraft. The absence of signed agreements leaves the schedule dependent on industrial capacity, technical validation and regulatory approvals.

The venture would place Reliance in competition with Starlink, which operates an established global satellite network, although the two systems differ in scale and geographic focus. Reliance’s proposed constellation is primarily directed towards national broadband coverage rather than matching Starlink’s worldwide operations.

At Reliance Industries’ annual general meeting in June, Ambani said Jio was evaluating a sovereign low Earth orbit constellation while also leasing capacity from established international operators. The two-track strategy is designed to offer satellite connectivity before its own spacecraft are available.

He said Jio was developing ground stations to support both partner networks and any future satellites. The company has outlined plans for 23 ground stations, which would connect spacecraft communications with terrestrial networks and help deliver services to customers.

Regulatory uncertainty remains another obstacle for the sector. Jio Satellite Communications, Starlink and Eutelsat OneWeb have obtained satellite communications licences, but commercial services still face spectrum allocation requirements and security clearances. Permission to operate does not by itself authorise an immediate nationwide launch. Operators must also establish compliant ground infrastructure before providing services commercially to consumers and businesses across the country.

On 5 November, the Telecom Regulatory Authority of India issued recommendations for a separate satellite network provider authorisation and associated spectrum assignment. Its proposals would allow authorised network operators to supply satellite infrastructure to eligible service providers, subject to government decisions and prescribed conditions.

The regulator also recommended allowing satellite-based direct-to-device services under specified spectrum arrangements. Such services would be distinct from conventional broadband connections using dedicated satellite terminals, and would depend on the applicable technical and licensing framework.

Reliance already has a satellite broadband venture with Luxembourg-based SES, established to use geostationary and medium Earth orbit capacity. That arrangement is separate from the proposed low Earth orbit constellation and forms part of Jio’s existing approach to securing satellite connectivity.

Apple has begun restoring services disrupted by an internal software update after outages affected the App Store, Apple Music and AppleCare, while iCloud account sign-ins encountered problems across its user base. The company acknowledged the disruption on Tuesday, 17 November, through its system status dashboard, which classified the App Store and Apple Music interruptions as outages and warned that iCloud Account & Sign In could be slow […]

PARIS, FRANCE – Media OutReach Newswire – 18 November 2026 – From 14 to 15 October 2026, the 2026 INPD Award was held at the Carrousel du Louvre in Paris, France. Under the annual theme “REGENERATIONS”, it gathered cosmetics research institutions and industry-chain companies worldwide to showcase frontier technologies and innovation.

China's Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award
China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award

Key C, a brand under Shandong Freda Biotech Co., Ltd., won the INPD Innovative Manufacturing Process Award with its proprietary Membrane-Penetrating Collagen Technology, marking a new stage in which China’s collagen technology moves from “following ingredients” to “exporting intelligent manufacturing”.

01 Ending the Pain Point That “Intact Collagen Is Too Large to Penetrate“

Recombinant collagen, being a large molecule, penetrates the skin with difficulty, yet degrading it into small molecules destroys the activity of the intact structure. Building on Freda’s more than three decades of synthetic biology expertise, the Key C R&D team used gene editing to fuse a cell-penetrating peptide segment into the sequence of recombinant type III humanised collagen. The technology preserves the active structure of the large molecule while enabling it to actively cross the skin barrier and enter cells; assessments confirm that it is internationally leading.

Rather than miniaturising molecules, Key C reconciled penetration capability with structural activity, opening a new direction for recombinant collagen applications in skincare.

The 24-hour subcutaneous penetration rate of Key C’s membrane-penetrating collagen is 2,750% higher than that of ordinary recombinant type III collagen, and within two hours 91.67% of skin cells achieve membrane penetration. It activates 11 key skin proteins and restores the vitality of 60-year-old skin cells to 99.77% of that of 20-year-old cells. The single-dose ampoule delivers four-fold cellular anti-wrinkle action, smoothing fine lines within 10 minutes and, after seven consecutive days of use, achieving improvement comparable to in-clinic procedures. Human trial data also earned it China’s first procedure-level anti-wrinkle skincare certification from SGS.

02 From Technological Breakthrough to Standard-Setting

Key C is turning its technological advantage into industry-wide rules. In 2025, Freda Key C led the drafting of China’s first group standard, “Recombinant Collagen Penetration, Degradation and Regeneration Testing — In Vivo Human Raman Spectroscopy Method”, introducing Raman spectroscopy into recombinant collagen efficacy evaluation and making “transdermal absorption” a precisely measurable parameter. The group standard it led, “Guidelines for Perioperative Skin Care in Medical Aesthetics”, also filled a gap in this field.

Key C and the Shandong Academy of Pharmaceutical Sciences jointly inaugurated the “Joint Research Center for Skin Longevity Science and Pharmaceutical Innovation R&D”, bringing pharmaceutical development logic into skincare innovation and establishing Key C as a rule-maker in recombinant collagen and light medical aesthetics skincare.

03 Taking the International Stage: China‘s Biomanufacturing Solution

Global beauty innovation is shifting from incremental formulation tweaks to foundational hard innovation such as synthetic biology and biomanufacturing. The debut and award of Key C’s Membrane-Penetrating Collagen Technology at 2026 INPD illustrates this trend, offering a referenceable Chinese pathway for the technological evolution of the global recombinant collagen sector.

Hashtag: #ChinaCosmeticsReview #INPDAward #KeyC

The issuer is solely responsible for the content of this announcement.

  • Prof. Svetlana Mojsov, Prof. Dr. Richard DiMarchi, and Prof. Dr. Dr. h.c. Matthias H. Tschöp honored for groundbreaking research on metabolic diseases and obesity therapies.
  • Minister-President Boris Rhein presents the medical award, endowed with a total of one million euros, at the Hessian State Chancellery.
  • Titia große Broermann: ” this year’s laureates powerfully demonstrate how scientific curiosity sparks medical progress that can transform millions of lives”

WIESBADEN, GERMANY – Newsaktuell – 17 November 2026 – Prof. Svetlana Mojsov (The Rockefeller University), Prof. Dr. Richard DiMarchi (Indiana University), and Prof. Dr. Dr. h.c. Matthias H. Tschöp (Ludwig-Maximilians-Universität München) have been awarded the Broermann Medical Innovation Award 2026. Hessian Minister-President Boris Rhein presented the award during a ceremony at the Hessian State Chancellery.

Endowed with a total of one million euros, the Broermann Medical Innovation Award ranks among the world´s highest-endowed medical honors. This year, it honors three scientists whose fundamental work contributed decisively to enabling modern GLP-1-based therapies against obesity and diabetes. The award was endowed by Dr. Bernard große Broermann, founder of the Asklepios Kliniken Group.

In the presence of representatives from science, politics, and society, Minister-President Boris Rhein praised the international significance of the honored research achievements:

Boris Rhein, Minister-President of Hesse: “Through their research, Prof. Dr. Richard D. DiMarchi, Prof. Dr. Svetlana Mojsov, and Prof. Dr. med. Dr. h.c. Matthias Tschöp have opened a new chapter in metabolic therapy. Their work laid the scientific foundation for what is colloquially known as the “weight-loss injection.” From fundamental insights into human metabolism, a new generation of therapies has emerged, paving the way for effective treatments for diabetes and obesity, while also helping to manage or reduce associated secondary conditions.”

Prof. Dr. Werner Seeger, Chairman of the Jury for the Broermann Award, emphasized: “The work of this year’s laureates powerfully proves how scientific pioneering transforms into medical reality. Their discoveries surrounding GLP-1 and polyagonists have fundamentally redefined obesity and diabetes care, offering real hope to millions worldwide.”

Prof. Svetlana Mojsov stated: “I am humbled and honored to receive the Broermann Award for my work on GLP-1 that began over 40 years ago with a hypothesis and has gone to benefit the health and lives of millions of people worldwide.”

Prof. Dr. Richard DiMarchi noted: ” In the last decade, based upon a half century of research we have progressed with incretin-based medicines to transform the management of excess body weight analogous to historical treatment of excess glucose, cholesterol, and blood pressure. It is providing a transformative advance in public health and patient well-being.”

Prof. Dr. Dr. h.c. Matthias H. Tschöp added: “It is a great honor to receive this recognition together with Svetlana Mojsov and Richard DiMarchi. We are delighted that our decades of work on the scientific foundation and invention of therapeutic principles that ignited the modern obesity-drug revolution is receiving international recognition. It is especially rewarding to see how these discoveries are transforming the therapeutic landscape of diabetes, cardiovascular disease, fatty liver disease, and many other obesity-related conditions worldwide.”

Titia Olivia große Broermann, Shareholder of the Asklepios Kliniken Group, added: “The Broermann Medical Innovation Award stands for the conviction that medical progress begins where scientific courage meets the determination to sustainably improve patients’ lives. This year’s awardees impressively demonstrate how scientific curiosity and decades of research can give rise to therapies that transform the lives of millions of people. With this award, we aim to make their outstanding achievements visible while encouraging researchers worldwide to forge new paths. On behalf of my family and the Asklepios Kliniken Group, I congratulate Prof. Mojsov, Prof. DiMarchi, and Prof. Tschöp from the bottom of my heart.”

Foundations for a New Generation of Therapies

Prof. Svetlana Mojsov, Prof. Dr. Richard DiMarchi, and Prof. Dr. Dr. h.c. Matthias H. Tschöp were honord for their fundamental contributions to metabolic science. Their work on elucidating bioactive GLP-1, signal transmission between the gut and brain, and the development of multi-hormone co-agonists (polyagonists) laid the foundation for modern drugs for weight regulation and blood sugar control.

About the Award Winners

Prof. Svetlana Mojsov (born in Skopje, North Macedonia) earned her PhD in biochemistry at The Rockefeller University under Nobel laureate Bruce Merrifield, focusing on solid-phase peptide synthesis. During her research at Massachusetts General Hospital and Harvard Medical School in the 1980s, she identified and chemically synthesized the active 31-amino-acid form of Glucagon-Like Peptide-1 (GLP-1) and demonstrated its physiological role in stimulating insulin secretion. Her groundbreaking discoveries proved vital for the later development of GLP-1 receptor agonists. She currently serves as a Research Professor at The Rockefeller University in New York.

Prof. Dr. Richard DiMarchi (born in New York, USA) earned his PhD in biochemistry at Indiana University. Following academic research at The Rockefeller University, he led major research and development divisions at Eli Lilly and Company for over two decades, where he played a pioneering role in shaping the development of human insulin and analogues (Humalog®) and rHGH (Humatrope®) As a world-renowned peptide chemist and innovator, he holds over 100 patents and has co-founded eight successful biotech companies. He is currently Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University.

Prof. Dr. Dr. h.c. Matthias H. Tschöp (born in Munich, Germany) completed his medical studies at Ludwig-Maximilians-Universität (LMU) München. Following clinical work in endocrinology and research at Eli Lilly, he established research laboratories at the University of Cincinnati and Helmholtz Munich. Tschöp discovered the key role of ghrelin as the hunger hormon and, in close collaboration with Richard DiMarchi, developed the concept of multi-hormone co-agonists (dual and triple gut hormone receptor agonists such as GLP-1/GIP and GLP-1/GIP/glucagon molecules). He currently serves as President of LMU Munich.

About the Broermann Medical Innovation Award

The Broermann Medical Innovation Award was established in 2024 by Dr. Bernard große Broermann, namesake and founder of Asklepios Kliniken. Throughout his lifetime, Dr. große Broermann was distinguished by his vision of creating an innovative healthcare company that delivers genuine benefits to people. Under his leadership, Asklepios set standards in medical innovation, targeted investments in state-of-the-art medical technology and digital solutions, and thereby advanced patient care—values that also

form the foundation of the Broermann Medical Innovation Award. Through this award, his vision lives on and underscores a commitment that endures beyond his lifetime through his foundation.

2027 Nomination Phase

The nomination phase for the Broermann Medical Innovation Award 2027 has begun. Scientists from around the world can be nominated until March 1, 2027. Further information on the award, nomination criteria, and the selection process is available on the Award-Website

High-resolution photos of the award ceremony will be available for download shortly after the event at the following website: https://www.broermann-award.org/press/

Broermann Medical Innovation Award
www.broermann-award.com
www.facebook.com/people/Broermann-Medical-Innovation-Award/61567211302915/
www.linkedin.com/company/broermann-medical-innovation-award/
www.instagram.com/broermannaward

Asklepios Kliniken
Visit Asklepios online and on social media:
www.asklepios.com
www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
de.linkedin.com/company/asklepios
www.instagram.com/asklepioskliniken/
www.facebook.com/asklepioskliniken
www.tiktok.com/@asklepioskliniken

The issuer is solely responsible for the content of this announcement.

Kochi police have arrested a man accused of assaulting his wife and forcing their pet pitbull to bite her during a domestic dispute, leaving her with a fractured nasal bone and an injured hand. The accused, identified as Sunil, a carpenter from Mundupalam in Karingamthuruth, Alangad, was formally arrested by Varapuzha…

Ukraine faces a $32.6 billion shortfall in external financing for 2027 as parliament races to complete budget and reform legislation linked to continued support from international lenders and the European Union. Finance Minister Sergii Marchenko told international partners that the country needs $52.6 billion in external funding next year, with roughly $20 billion covered by identified or expected sources. The figures, reiterated at the Ukraine Donor Platform […]

Abu Dhabi’s Mubadala Investment Company and US investment firm Centerbridge Partners have agreed to acquire Canaccord Genuity’s wealth management operations in Britain and the Crown Dependencies for an enterprise value of approximately £1.17 billion ($1.54 billion). The all-cash agreement, announced by the companies on Monday, covers Canaccord Wealth, which managed and administered £43.4 billion in client assets as of 30 June 2026. The purchase is expected to […]

Microsoft has restored its Microsoft 365 services after a worldwide outage disrupted Outlook email, parts of Teams and Copilot, with a preliminary investigation identifying a software defect that overwhelmed its cloud networking infrastructure. The company said the disruption, which began on Thursday, 12 November, lasted almost 24 hours before active customer impact ended on Friday. Its preliminary post-incident report, dated 15 November, traced the failure to three […]

Arabian Post Staff -Dubai First Abu Dhabi Bank plans to raise up to AED15 billion ($4.1 billion) through a rights issue, seeking shareholder approval for one of the Middle East’s largest bank capital raisings as it prepares to expand lending and investment. The UAE’s biggest lender by assets said its board had approved the proposal to issue 1,109,467,456 new shares at AED13.52 each. The offer price represents […]

Arabian Post Staff -Dubai Dubai International Airport handled 50.4 million passengers in the first nine months of 2026, a 28.1 per cent decline from a year earlier as the Middle East conflict disrupted flights, operator Dubai Airports said on Tuesday. The figures showed traffic remained substantially below last year’s levels despite an improvement during the summer. Passenger numbers reached 18.8 million in the July-to-September quarter, down 22.1 […]

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 and provides 2027 outlook update.

3Q26 Business and Financial Highlights
  • Record quarterly revenue of NT$6,453 million, up 9.6% QoQ; basic EPS of NT$4.79, up 9.9% QoQ. Building on 2Q26 momentum, revenue increased by NT$564 million QoQ and operating income by NT$104 million. Excluding one-time M&A-related costs in both quarters, operating income would have increased approximately NT$ 140mn QoQ.
  • Year-to-date, CDMO wins span across controlled substances, complex oral solids, high potency products, sterile ophthalmic and biologics across U.S., Canadian and Taiwan sites; investments of the past few years are expected to contribute to profitability from 2H27.
  • Near term, CDMO 12-month rolling backlog reached US$340 million as of end-3Q26. Backlog build partly reflects the timing of conversion at the Maryland injectables site, where quality and technical platform upgrades are underway ahead of scaled production and a semi-annual maintenance shutdown in September.
  • Pharma sales revenues rose 12.5% QoQ and 9.3% YoY. Specialty and brand franchises grew 22.4% over 2025 average quarterly run rate and market leadership of DLS and other leading generics sustained. With growth momentum restored, the pharma sales business firmly anchors the Group’s revenue and earnings as CDMO enters its accelerated growth phase.
  • Share capital increased 0.3% during the quarter from employee stock option exercise.
Mr. Bobby Sheng, Chairman of Bora Group, stated, “In 2026, customers are choosing Bora because we combine onshore North American capacity with capabilities rarely found in a network of our size. Our focus now is execution: completing these commercial technology transfers in our US facilities on time, qualifying our new isolator fill-finish capacity, where 4 PPQ batches have been completed and 3 additional technology transfer programs are scheduled for 2027, and delivering on every quality commitment we have made.

“The acquisitions we completed between 2024 and 2026, supported by US$55 million in cumulative capital investment, more than 50% of it in specialized onshore capabilities, have broadened our offering and are now converting into wins, which we expect to translate into commercial revenue over the next 3 to 5 years. Near term, elevated financing costs continue to weigh on net profit, and sites still ramping toward full utilization are affecting our gross margin mix. We are now in the final stretch of this investment cycle.

Year-to-date CDMO wins reached an exceptional all-time high of US$437 million, driven predominantly by multi-year commercial agreements and a deepening pre-commercial portfolio. These programs are expected to bring 24 new molecules into the Bora network, including 5 novel molecules across preclinical to registration, adding to the approximately 110 molecules we manufacture or process each quarter. Together, they extend our visibility from a 12-month backlog of US$340 million to more than 5 years of recurring commercial supply, supported by a pipeline of client programs that includes first-in-class therapies and treatments for diseases with no approved options.

Building on this momentum, we delivered both sequential and year-over-year growth at the operating level in the quarter, even as recently acquired and expanded sites are ramping toward full utilization and profitability. I am also encouraged by the team’s diligence in financial management as our CDMO business enters a new phase. Since last year, we have refocused our Pharma Sales strategy on defending and maximizing leading products, leveraging our strong manufacturing capability, and streamlining smaller products that tied up working capital. As a result, net working capital as a percentage of revenue reached its lowest level since the integration of Upsher-Smith, keeping Bora Group well positioned through periods of global currency and liquidity volatility.

The Group will operate under one financial discipline with shared capabilities. To move from design to delivery, we established a group-wide procurement function and a CDMO manufacturing science and technology (MSAT) team in 2026. As we complete this investment cycle, we expect these synergies to surface in margin.”

3Q26 Operational Achievements & 2027 Outlook
Global CDMO Operations
CDMO revenue, including internal orders, rose 14.9% YoY, driven by both organic and acquisition-led scale expansion, and eased 0.5% QoQ, reflecting production timing at the Maryland injectables site during its quality and technical platform upgrades. External CDMO revenue reached NT$2,085 million, up 16.9% YoY and down 1.5% QoQ. Notably, Bora manufactured 0.44 billion doses during the quarter. External orders have now backfilled the internal volume released as the Group streamlined smaller, highly competitive generics in 2025, restoring network utilization to healthier levels.

Looking into 4Q26 and 2027, the Company is excited to see how biologics demand is shifting in our favor as sponsors are choosing partners on speed and risk mitigation. Capital is flowing to clinical-stage assets with a clear path to market, and biotech business models are evolving, with sponsors retaining their programs deeper into the clinic and through approval and commercialization and hence greater outsourcing needs. Simultaneously, rare-disease, immunotherapy and personalized medicines need lower volumes, yet commercially compliant cGMP capacity at that scale remains scarce. The orphan drug CDMO market alone is projected to more than double, from USD 15.2 billion in 2025 to USD 32.4 billion by 2035, with North America the largest market and Asia-Pacific the fastest growing, according to Spherical Insights, which names Bora Group among the top CDMO companies in the space.

We are realigning our biologics assets to capture this demand. Rockville, which joined the Group in July, brings cell line development, R&D and process development laboratory capabilities alongside late-stage and commercial manufacturing, connecting Tanvex’s Zhubei and San Diego sites into a tri-site network servicing small and mid-sized biotechs. Programs can now move from early development to commercial supply without leaving the network. The realignment also reflects slower-than-planned uptake of new capacity in San Diego, and we expect it to be completed within the next 2 quarters.

Pharma Sales Operations

Revenue increased by 9.3% year-over-year and 12.5% quarter-over-quarter, arriving at NT$3,302 million in 3Q26, the first quarter of growth on both measures since the beginning of 2025. Revenue included a one-time licensing income from Megestrol Acetate ex-China.

Specialty and brand products reached 47.0% of Pharma Sales revenue, with revenue 22.4% above the 2025 average quarterly run rate. The Vigabatrin franchise, our anchor rare-disease asset, continued to broaden patient access: formulary coverage exceeded our year-end goal in September, and inpatient channels are expanding. Incremental volume is supplied under the renegotiated supplier contracts, lifting the franchise’s economic contribution. Meanwhile, generics climbed back up as DLS reclaimed market leadership, narrowing the year-to-date impact of pricing.

CHC Operations

Sunway delivered its first full quarter at its new scale following the integration of Weider Global Nutrition. 3Q26 revenue of NT$1,063 million and operating income of NT$73 million each exceeded the full 1H26 total. As one-time acquisition costs wound down, the OPEX ratio fell to 35.2% from 38.2%, lifting operating margin to 6.9%. Year-to-date net income reached 22 times last year’s level, with core operations now generating most of pre-tax profit. Unlike the 2021 peak, today’s results rest on a more balanced end-market mix and a growing portfolio of own brands with direct channel access.

Recent Investor Conference

Bora will host English and Chinese online earnings call at 4:30 p.m. Taiwan time on Nov. 13th, 2026. The event will cover the Company’s 3Q26 financial and business results and 2027 outlook.

Online Earnings Presentation and Replay Link: https://morganstanley.webcasts.com/starthere.jsp?ei=1781786&tp_key=5f9370f519

Bora will participate in Jefferies London Healthcare Conference in November. For 1:1 meetings with management, please contact your Jefferies representative.

Bora 2026 Earnings Schedule

Q4 2026: Expected in the 2nd week of Mar 2027

Disclaimer:

This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.

Hashtag: #BoraPharmaceuticals

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.

For more, please visit:

The Kerala State Electricity Regulatory Commission (KSERC) has raised 15 questions over the transaction and asked Kerala State Electricity Board Limited (KSEB) to respond by November 18. The regulator has sought details of the generating source, delivery schedule, electricity supplied and the basis for fixing the tari…

Arabian Post Staff -Dubai ADQ Aviation has acquired another 12.17% of Abu Dhabi Aviation, lifting its controlling interest in the Abu Dhabi-listed aviation services company to 71.61%, the exchange disclosed on Monday. The transaction involved 133.44 million shares bought from Mamoura Diversified Global Holding, consolidating the investment held by ADQ Aviation and Aerospace Services, an entity indirectly wholly owned by Abu Dhabi government investor L’imad Holding. Abu […]

Fitch Ratings has affirmed the UAE’s sovereign credit rating at AA- with a stable outlook, forecasting modest economic growth in 2026 despite disruption from the Iran war. The agency expects real gross domestic product to increase by 0.5 per cent this year, supported by higher hydrocarbon production even as the non-oil economy contracts. Its assessment, issued on Friday, highlights the country’s substantial financial reserves and comparatively low […]

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA
Just in:
Jaiedco and Golden Bridge Announce Strategic Collaboration for a New Dubai Islands Development // Padmini follows Padmaja for ‘ghar vapsi’ // Dalilk Academy reaches 27 million, targets 100 million by 2030 // Antony’s wife called to police station with husband over complaint // Alibaba shares slip despite 53% cloud revenue growth // PicCollage extends photo editing platform to web browsers // Travel Insurance Was Built for the Few Who Claim. Ancileo’s Felt Coverage™ is for Everyone Else // Sui activates Hashi Bitcoin lending across partner network // Russia permits retail cryptocurrency purchases under regulated framework // Dubai Introduces SHARH, an AI-Powered Platform Helping Entrepreneurs Buy, Sell and Manage Businesses in the UAE // Sharjah clears Kalba free zone plan for 400MW complex // Sabarimala booking discrepancies prompt sabotage angle probe // Coinbase targets 2027 launch amid state gambling lawsuits // Workday targets Honeydew purchase to unify AI metrics // Yeebo Announces Interim Results for FY26/27 Revenue Increases by 45.5% to HK$806.7 Million Profit Attributable to Owners Surges 87.6% to HK$2,284.7 Million // Hackers exploit public notes to distribute NodeLinkRAT malware // Promoting Common Human Development Through Exchanges and Mutual Learning Among Civilizations // Malappuram hartal over Western Ghats // Oil futures rebound after Riyadh strikes and tanker alerts // LittleLives, Little Lab and SEGi College Sign MOU to Explore Early Childhood Education Collaboration Across ASEAN //